Insilico Biotechnology

insilico-biotechnology.com

Insilico Biotechnology is a market-leading company providing predictive solutions for the Bioeconomy. An interdisciplinary team of experts offers mechanistic models, customized software, and a high performance computing platform for the simulation of living cells. For world-leading pharma and biotech companies Insilico's technology lowers time, risk and costs of bioprocess development. Founded in 2001, Insilico is a privately held company based in Stuttgart, Germany. For more information please visit www.insilico-biotechnology.com.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Cell and Gene Therapy

ENARA BIO RELOCATES TO THE OXFORD SCIENCE PARK'S NEWEST FACILITY TO EXPAND R&D CAPABILITIES

Enara Bio | December 09, 2020

news image

Enara Bio, a biotechnology organization utilizing its proprietary T-cell/T-cell receptor (TCR) discovery and Dark Antigen™ platforms to deliver focused on cancer immunotherapies, announces its extension and move to the new Bellhouse Building at The Oxford Science Park. Enara Bio's move from the Oxford BioEscalator to one of the UK's biggest biomedical advancement habitats is in anticipation of its future development and desire to change malignancy care. The devoted exploration offi...

Read More

Cell and Gene Therapy

BOSTON LABS AND GERMFREE LAUNCH MOBILE CELL AND GENE THERAPY (CGT) MANUFACTURING PLATFORM

BOSTON LABS | September 23, 2021

news image

Clinical logistics and life science manufacturing leaders Boston Labs and Germfree Laboratories Inc. announced their partnership to launch a new network of mobile CGT manufacturing facilities. The two companies are combining deep logistics, CGT manufacturing expertise and mobile cleanroom technology to deliver CGT point-of-care contract manufacturing services. The CGT mobile manufacturing platform will launch in Boston, MA in the fourth quarter of 2021 and will scale to a network ...

Read More

Research

SKYE BIOSCIENCE ESTABLISHES NEW CANNABINOID PHARMACEUTICAL INNOVATION PROGRAM

Skye Bioscience, Inc. | October 13, 2021

news image

Skye Bioscience, Inc. (“Skye” or the “Company”), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, has formed a new exclusive sponsored research agreement with Emerald Health Biotechnology Espana SLU (“EHBE”), focused on developing and characterizing novel molecules that can affect the endocannabinoid system (ECS) for therapeutic benefit. The research in...

Read More

Industry Outlook

CRESILON RECEIVES FIRST FDA CLEARANCE FOR HUMAN USE OF HEMOSTATIC GEL TECHNOLOGY

PRNewswire. | July 03, 2023

news image

Cresilon, Inc. a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, announced that it has been granted 510(k) clearance from the U.S. Food and Drug Administration ("FDA") for Cresilon Hemostatic Gel™ ("CHG™"). This marks Cresilon's first FDA clearance for human use, validating its revolutionary hemostatic gel technology and the company's global mission to transform wound care. CHG™ util...

Read More
news image

Cell and Gene Therapy

ENARA BIO RELOCATES TO THE OXFORD SCIENCE PARK'S NEWEST FACILITY TO EXPAND R&D CAPABILITIES

Enara Bio | December 09, 2020

Enara Bio, a biotechnology organization utilizing its proprietary T-cell/T-cell receptor (TCR) discovery and Dark Antigen™ platforms to deliver focused on cancer immunotherapies, announces its extension and move to the new Bellhouse Building at The Oxford Science Park. Enara Bio's move from the Oxford BioEscalator to one of the UK's biggest biomedical advancement habitats is in anticipation of its future development and desire to change malignancy care. The devoted exploration offi...

Read More
news image

Cell and Gene Therapy

BOSTON LABS AND GERMFREE LAUNCH MOBILE CELL AND GENE THERAPY (CGT) MANUFACTURING PLATFORM

BOSTON LABS | September 23, 2021

Clinical logistics and life science manufacturing leaders Boston Labs and Germfree Laboratories Inc. announced their partnership to launch a new network of mobile CGT manufacturing facilities. The two companies are combining deep logistics, CGT manufacturing expertise and mobile cleanroom technology to deliver CGT point-of-care contract manufacturing services. The CGT mobile manufacturing platform will launch in Boston, MA in the fourth quarter of 2021 and will scale to a network ...

Read More
news image

Research

SKYE BIOSCIENCE ESTABLISHES NEW CANNABINOID PHARMACEUTICAL INNOVATION PROGRAM

Skye Bioscience, Inc. | October 13, 2021

Skye Bioscience, Inc. (“Skye” or the “Company”), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, has formed a new exclusive sponsored research agreement with Emerald Health Biotechnology Espana SLU (“EHBE”), focused on developing and characterizing novel molecules that can affect the endocannabinoid system (ECS) for therapeutic benefit. The research in...

Read More
news image

Industry Outlook

CRESILON RECEIVES FIRST FDA CLEARANCE FOR HUMAN USE OF HEMOSTATIC GEL TECHNOLOGY

PRNewswire. | July 03, 2023

Cresilon, Inc. a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, announced that it has been granted 510(k) clearance from the U.S. Food and Drug Administration ("FDA") for Cresilon Hemostatic Gel™ ("CHG™"). This marks Cresilon's first FDA clearance for human use, validating its revolutionary hemostatic gel technology and the company's global mission to transform wound care. CHG™ util...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us